Veracity Capital LLC Abb Vie Inc. Transaction History

Veracity Capital LLC

$261 Million
Q3 2024

A detailed history of Veracity Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Veracity Capital LLC holds 4,344 shares of ABBV stock, worth $745,995. This represents 0.33% of its overall portfolio holdings.

Number of Shares

4,344

Previous 4,366 0.5%

Holding current value

$745,995

Previous $748,000 14.57%

% of portfolio

0.33%

Previous 0.31%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$163.84 - $199.33 $3,604 - $4,385	-22 Reduced 0.5%	4,344 $857,000
Q2 2024 Jul 22, 2024	SELL	$154.79 - $180.76 $145,347 - $169,733	-939 Reduced 17.7%	4,366 $748,000
Q1 2024 Apr 19, 2024	SELL	$159.82 - $182.1 $53,539 - $61,003	-335 Reduced 5.94%	5,305 $966,000
Q4 2023 Jan 22, 2024	BUY	$137.6 - $154.97 $23,392 - $26,344	170 Added 3.11%	5,640 $874,000
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $31,126 - $36,033	233 Added 4.45%	5,470 $815,000
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $10,335 - $12,862	-78 Reduced 1.47%	5,237 $705,000
Q1 2023 Apr 06, 2023	SELL	$144.61 - $166.54 $10,122 - $11,657	-70 Reduced 1.3%	5,315 $847,000
Q4 2022 Jan 17, 2023	BUY	$138.31 - $165.87 $7,192 - $8,625	52 Added 0.98%	5,385 $0
Q3 2022 Oct 17, 2022	BUY	$134.21 - $153.93 $25,365 - $29,092	189 Added 3.67%	5,333 $716,000
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $275 - $349	-2 Reduced 0.04%	5,144 $788,000
Q1 2022 Apr 18, 2022	BUY	$131.98 - $163.75 $202,721 - $251,520	1,536 Added 42.55%	5,146 $834,000
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $21,056 - $26,642	196 Added 5.74%	3,610 $489,000
Q3 2021 Oct 13, 2021	SELL	$106.4 - $120.78 $4.61 Million - $5.24 Million	-43,371 Reduced 92.7%	3,414 $368,000
Q2 2021 Aug 24, 2021	SELL	$105.21 - $117.21 $6.44 Million - $7.17 Million	-61,181 Reduced 56.67%	46,785 $5.21 Million
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $11 Million - $12.3 Million	104,648 Added 3153.95%	107,966 $460,000
Q1 2021 Sep 10, 2021	SELL	$102.3 - $112.62 $10.7 Million - $11.8 Million	-104,809 Reduced 96.93%	3,318 $359,000
Q1 2021 Apr 12, 2021	BUY	$102.3 - $112.62 $10.8 Million - $11.8 Million	105,175 Added 3562.84%	108,127 $464,000
Q4 2020 Sep 10, 2021	SELL	$80.49 - $108.67 $8.44 Million - $11.4 Million	-104,809 Reduced 97.26%	2,952 $316,000
Q4 2020 Jan 25, 2021	BUY	$80.49 - $108.67 $8.35 Million - $11.3 Million	103,706 Added 2557.48%	107,761 $421,000
Q3 2020 Sep 10, 2021	SELL	$85.91 - $100.83 $5.26 Million - $6.17 Million	-61,181 Reduced 93.78%	4,055 $355,000
Q3 2020 Oct 21, 2020	BUY	$85.91 - $100.83 $4.43 Million - $5.19 Million	51,518 Added 375.55%	65,236 $416,000
Q2 2020 Sep 10, 2021	SELL	$73.37 - $98.18 $4.49 Million - $6.01 Million	-61,181 Reduced 81.68%	13,718 $1.35 Million
Q2 2020 Jul 13, 2020	BUY	$73.37 - $98.18 $3.59 Million - $4.81 Million	48,972 Added 188.88%	74,899 $1.41 Million
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $1.4 Million - $2.13 Million	21,751 Added 520.86%	25,927 $1.98 Million
Q4 2019 May 07, 2020	BUY	$72.13 - $90.25 $301,214 - $376,884	4,176 New	4,176 $370,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veracity Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veracity Capital LLC with notifications on news.

Account

Veracity Capital LLC Abb Vie Inc. Transaction History